Status:
COMPLETED
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Long COVID
Long Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings where it can be integra...
Detailed Description
Participants will be randomized to one of the intervention appendices that are actively enrolling at the time of randomization. Intervention appendices may be added or removed according to adaptive de...
Eligibility Criteria
Inclusion
- 1\. See NCT05965752 for RECOVER-NEURO: Platform Protocol level inclusion criteria which applies to this appendix
Exclusion
- 1\. See NCT05965752 for RECOVER-NEURO: Platform Protocol level exclusion criteria which applies to this appendix
- Additional Appendix (Sub-study) Level
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2024
Estimated Enrollment :
328 Patients enrolled
Trial Details
Trial ID
NCT05965739
Start Date
September 1 2023
End Date
December 17 2024
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All sites listed under NCT05965752
Durham, North Carolina, United States, 27710